Press release
Cardiovascular Peptides Market - Evolving Technology, Trends, Opportunity and Industry Analysis – 2024
Request a PDF Brochure with Report Analysis: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=6263
Peptides developed for the treatment and prognosis of cardiovascular diseases include lactokinins, casokinins, gliadin hydrolysate, wheat gluten hydrolysate, casoplatelin, casopiastrin and peptides derived from β-LG. These peptides have different therapeutic indications depending on their biological activity. For instance, lactokinins, casokinins and gliadin hydrolysate are used in the treatment of hypertension whereas; casoplatelin and casopiastrin are indicated for the treatment of thrombosis.
The global cardiovascular peptides market can be analyzed from the therapeutic indication point of view and from the geographical aspect. Based on the geography, the global cardiovascular peptides market is categorized in four major segments - North America, Europe, Asia Pacific and Rest of the World.
Global Cardiovascular Peptides Market: Trends and Opportunity
Research and development in this arena has surged significantly realizing the therapeutic efficacy of peptide-based active pharmaceutical ingredients. Companies are collaborating to expedite the development of new peptide-based pharmaceutical product. Nile Therapeutics Inc. and Capstone Therapeutics are working in collaboration with American Peptide Company to develop peptide-based therapies for cardiovascular diseases, specifically for heart failure. Nile’s CD-NP is a novel natriuretic peptide in the clinical development stage intended for the treatment of acute decompensated heart failure (ADHF).
This peptide is intended to reduce pressure between the heart and the lungs and improve kidney function while attenuating hypotension by having least effect on the systemic blood pressure. Positive results from the trials would lead to the development of a natriuretic peptide for cardiovascular disease with better efficacy than the current therapies.
According to the World Health Organization (WHO) cardiovascular is the leading cause of death globally of which about 80% occur in the low- and middle-income countries. Moreover, it is projected to be the leading cause of death till 2030. Development of a targeted novel peptide for the treatment of cardiovascular disorders, would improve the treatment regimen to a great extent. Life expectancy of patients would increase significantly.
Moreover, peptide therapeutics holds vast opportunities in the Asia Pacific and Latin American regions where cardiovascular disorders are a major cause of deaths. According to the Heart Foundation, cardiovascular is the leading cause of death in Australia which caused 43,946 deaths in 2012. Targeted cardiovascular peptide therapies would decrease the risk of heart failure by reducing the associated risks of peripheral arterial diseases, myocardial infarction and hypertension.
Significant benefits of peptides such as fewer immunogenicity issues than biologics and flexibility in terms of manufacturing all types of formulations have been the major reasons for increased interest of pharmaceutical companies in developing cardiovascular peptide therapeutics. However, short serum half-life, and sensitivity to serum and tissue proteases have been the major restraints for the commercialization of products in the market. This however, is would be addressed with development of new technologies creating a great potential for the future of cardiovascular treatment therapies.
Browse Research Report: http://www.transparencymarketresearch.com/cardiovascular-peptides-market.html
Global Cardiovascular Peptides Market: Key Players
Some of the key players involved in the global cardiovascular peptides market include F. Hoffmann La Roche, Merck, Nile Therapeutics Inc., Biocon, Nobex Corporation, Capstone Therapeutics and American Peptide Company.
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cardiovascular Peptides Market - Evolving Technology, Trends, Opportunity and Industry Analysis – 2024 here
News-ID: 409922 • Views: …
More Releases from TMR
Emerging Opportunities in Logistics Market with Current Trends Analysis
The global Logistics market is estimated to attain a valuation of US$ 15,273.21 Bn by the end of 2027, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 4.5% during the forecast period, 2019-2027.
The key objective of the TMR report is to offer a complete assessment of the global market including major leading stakeholders of the…
Energy Measurement IC Market is expected to reach US$ 8.39 Bn by the end of 2031
According to a Transparency Market Research (TMR) research report, the global energy measurement ic market is likely to expand at a CAGR of 7.4% during the forecast period, 2022 to 2031. This suggests that the market is expected to reach US$ 8.39 Bn by the end of 2031.
The study on the energy measurement ic market adopts rigorous and systematic research approaches to understand the growth dynamic of the market. The…
STATCOM UPS Market to Register Double Digit Growth Rate of 16% CAGR by 2024
Over the last decade, rising number of industries and utilities are opting for static synchronous compensator or STATCOM UPS instead of static VAR compensator or SVC UPS. Low harmonic emission coupled with high speed of response is accentuating the expansion of India STATCOM UPS market now and in times to come. Playing a crucial role in voltage control and compensation of reactive power, STATCOM UPS is likely to keep its…
Thin Wafer Processing and Dicing Equipment Market US$692.5 mn by 2024 - TMR
Transparency Market Research (TMR) estimates that the global thin wafer processing and dicing equipment market has a highly consolidative landscape. Disco Corp. accounted for largest share of 56.4% in 2015 and likely to be dominant in the coming years. This is creating monopoly in the thin wafer processing and dicing equipment market in terms of competitive presence. The other key players such as EV Group, Plasma-Therm LLC, Lam Research Corp,…
More Releases for Peptide
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth…
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension…
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…
Growing Adoption of Synthetic Peptide Drugs Driving Peptide Therapeutics Market …
Peptide Therapeutics Market size was valued at USD 40.69 billion in 2019 and is poised to grow from USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031).
[https://www.skyquestt.com/report/peptide-therapeutics-market] size was valued at USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031). The increasing prevalence of…
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global…
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…
